Navigation Links
Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results
Date:2/8/2010

fectively reduce symptoms such as fever, shakes, cough, shortness of breath, and sore throat. According to Tianyin's market research and estimation, annual sales of this type of products are approximately $1.1 billion in China. The Antibacterial/Anti-inflammatory Capsules are a generic OTC TCM used as natural antibiotics to treat bacterial infection and inflammation with minimal side effects as compared to western antibiotics. Tianyin estimates that total annual sales of associated with products in this category are approximately $1.5 billion in China. -- Tianyin announced that 23 of its medicine compounds were included in the 2009 Edition of the National Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Medicine Directory, which lists a total of 2,151 medicines and became effective on December 1, 2009. The 23 medicines treat a variety of common indications and diseases and make up approximately 70% of Tianyin's total revenues for the fiscal year 2009. -- On January 11, 2010, Tianyin declared a quarterly cash dividend of 2.5 cents to be paid to its common stock shareholders for the fiscal second quarter of 2010 on March 10, 2010. -- On January 13, 2010, Tianyin received approvals from the Chinese State Food and Drug Administration (SFDA) to produce two generic antibiotics, Ofloxacin Tablets and Fleroxacin Tablets, which target new indications for the Company. Ofloxacin addresses several indications including staph, strep throat (Streptococcus), pneumonia, E. Coli, and several sexually transmitted bacterial diseases. Fleroxacin addresses several indications including chronic and acute bronchitis and pneumonia, salmonella, multiple gastrointestinal and abdominal infections, and skin/soft tissue infections. Both drugs are included in China's Essential Drug Li
'/>"/>
SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Tianyin Pharmaceutical Co., Inc. Reports Record Fiscal 2009 Financials With $7.9 Million in Net Income
2. Tianyin Pharmaceutical Co., Inc. to Host Fiscal 2009 Earnings Conference Call on Thursday, September 24, 2009 at 10:30 a.m. ET
3. Tianyin Pharmaceutical Co., Inc. Obtains GMP Certification for Its New Production Facility
4. Tianyin Pharmaceutical, Co. to Present at the Rodman & Renshaw Annual Global Investment Conference on September 11 at 10:50 am ET
5. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Sanqi Tablets and Yinqiao Jiedu Tablets
6. Tianyin Pharmaceutical Co., Inc. Announces Cash Dividend to Common Stockholders
7. Tianyin Pharmaceutical Co., Inc. Adopts New Sales Strategy for Azithromycin Dispersible Tablets
8. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Wednesday, February 18, 2009 at 8:45 a.m. EST
9. Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth
10. Tianyin Pharmaceutical Co., Inc. Announces First Quarter 2009 Financial Results
11. Tianyin Pharmaceutical Co., Inc. to Present at Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008 at 12:00 p.m. EST
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... NEW YORK , July 28, 2015 ... "Company"), a diversified life sciences company, today announced that ... authorized shares of common stock of the Company from ... held on July 27, 2015 at the Law Offices ... Meeting").   At the Special Meeting, there were 480,655,929 shares ...
(Date:7/28/2015)... PRUSSIA, Pa. , July 28, 2015 ... Food and Drug Administration has accepted for review the ... recombinant factor VIII single-chain (rVIII-SingleChain) for the treatment of ... all primary endpoints. Hemophilia A ... or defective factor VIII; nearly all affected patients are ...
(Date:7/28/2015)... July 28, 2015  Faced with increasing challenges ... palliative rather than symptomatic, the global healthcare industry ... therapies capable of curing or significantly changing the ... to look towards regenerative medicine as a viable ... paradigm in human health with the potential to ...
(Date:7/27/2015)... ... July 27, 2015 , ... This is ... report provides a basic overview of the industry including definitions, classifications, applications and ... including development trends, competitive landscape analysis, and key regions development status. Development policies ...
Breaking Biology Technology:Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 3U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 2Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 4Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 52015 Biophotonics Market Global Research 22015 Biophotonics Market Global Research 3
... Bridge presents Autism Research Institute,s Defeat Autism Now!(R) ... Suites Hotel and Convention Center at 2501 Conference ... devoted to educating doctors, parents and professionals. Presenters ... Rossignol, MD; and Doreen Granpeesheh, PhD, will discuss ...
... /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine ... 3-year research agreement with Defence Research and Development ... application of IVT,s DepoVax(TM) vaccine formulation to anthrax ... for, and respond to biological threats. , "Dr. ...
... -- Phase 1 Data from Colorectal Cancer and Oral ... April 14 Poniard Pharmaceuticals, Inc. (Nasdaq: ... announced that the Company will present final data from ... lead product candidate, at poster sessions during the American ...
Cached Biology Technology:Defeat Autism Now!(R) Regional Conference to be Held in Oklahoma June 13-14, 2009 2ImmunoVaccine Technologies Collaborates with Defence Research & Development Canada to Strengthen Canada's Ability to Deal with Biological Threats 2Poniard Pharmaceuticals to Present Final Data from Picoplatin Phase 1 Clinical Trials at American Association for Cancer Research's 100th Annual Meeting 2
(Date:7/13/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market, announced ... for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD AND SYSTEM. ... secure method to make payments.  With this patent, ... with its groundbreaking voice-direct payment patent application, with ...
(Date:7/9/2015)... Research and Markets( ... "Biometrics for Banking; Market & Technology Analysis, ... their offering. The adoption for banking ... and the forecast is that by 2020 it ... involved in delivering biometric systems to the banking ...
(Date:7/9/2015)... , July 9, 2015  Synaptics Inc. ... of human interface solutions, today announced a ... first fully hardware encapsulated fingerprint sensor and ... technology is literally off the grid, isolating ... matching within the fingerprint sensor to provide ...
Breaking Biology News(10 mins):NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3
... the amount of saleable product while reducing dietary inputs ... researchers have been looking at how dietary components affect ... important nutritional outcome is how well an animal is ... Dilger. Poultry and swine nutritionists are concerned ...
... of the large family of rove beetles (Staphylinidae) have been discovered ... an exploration of the insect fauna of the Liupan Shan ... collected. The expedition also yielded 11 new records for the Ningxia ... the open access, peer reviewed journal Zookeys . ...
... This release is available in French . ... back pain after a car accident, avoiding the harmful effects ... is particularly important for people with a smaller-than-average hippocampus, as ... are the findings of a study by Dr. Pierre Rainville, ...
Cached Biology News:Promoting poultry health through diet 2Promoting poultry health through diet 3Promoting poultry health through diet 44 new species of water-gliding rove beetles discovered in Ningxia, China 2Preventing chronic pain with stress management 2
The improved design and new mechanical solutions of Finnpipette Focus Multichannel Plus improves accuracy and precision.In these low volume multichannel pipettes, the super blow-out function ensures ...
Spectrolyse (pL) PAI kit is a two-stage indirect enzymatic assay for the quantitative determination of Plasminogen Activator Inhibitor (PAI-1) activity in plasma. Sample Type: plasma...
... Physical Form: buffered aqueous solution. ... galactose from complex carbohydrates and glycoproteins. It ... under conditions where the pH must be ... cells. Unit Definition: ...
Rabbit anti-CRSP1 (TRAP220), Polyclonal Antibody, Unconjugated Applications: Immunohistochemistry - 1:100 - 1:500...
Biology Products: